Alkem Labs receives two USFDA observations for Baddi facility in Himachal

Drug firm Alkem Laboratories on Friday said it has received two observations from the US health regulator after inspection of its Baddi facility in Himachal Pradesh. "At the end of inspection, the company has received a Form 483 with two observations," it added.

Feb 21, 2020 03:02 IST Source : Business Standard

Alkem
Drug firm Alkem Laboratories on Friday said it has received two observations from the US health regulator after inspection of its Baddi facility in Himachal Pradesh. "At the end of inspection, the company has received a Form 483 with two observations," it added.

Related Story